Skip to main content

Table 3 Association between vaccination and embryo ploidy on crude and adjusted analysis

From: Impact of inactivated SARS-CoV-2 vaccination on embryo ploidy: a retrospective cohort study of 133 PGT-A cycles in China

 

Crude β (95% CI)

Adjusted β (95% CI)*

Adjusted P-value*

No. of aneuploid embryos

0.06 (-0.42–0.53)

-0.10 (-0.63–0.42)

0.696

No. of mosaic embryos

-0.30 (-0.70–0.09)

-0.67 (-1.41–0.07)

0.076

No. of euploid embryos

0.03 (-0.41–0.47)

0.02 (-0.41–0.44)

0.942

Aneuploidy rate (%)

0.04 (-0.09–0.16)

0.03 (-0.09–0.15)

0.629

Mosaicism rate (%)

-0.04 (-0.14–0.05)

-0.04 (-0.14–0.06)

0.445

Euploidy rate (%)

0.01 (-0.08–0.09)

0.01 (-0.08–0.10)

0.850

  1. CI, confidence interval
  2. *Adjusted for parental age and body mass index, male vaccination status, infertility type, duration and diseases, anti-müllerian hormone, antral follicle count, ovarian stimulation protocol, and indication for PGT-A